Sterilox Technologies, Inc. Announces FDA Clearance of the Sterilox Liquid Chemical Disinfectant System.
RADNOR, Pa. -- Sterilox Technologies, Inc. announced today that it has received clearance of its 510(k) from the Food and Drug Administration (FDA) to market its Sterilox Liquid Chemical High Level Disinfectant System. The company plans to launch the product in the United States over the coming months. The Sterilox System has been marketed in Europe since 1999.
The Sterilox Liquid Chemical High Level Disinfectant (HLD) System, developed and patented by Sterilox Technologies, Inc., is a proprietary system that delivers to the end user a highly effective, non-toxic and biodegradable disinfectant from a proprietary, Sterilox designed, generator. The Sterilox HLD is the first new chemistry cleared by the FDA for the High Level Disinfection of heat sensitive instruments since 1999 and will provide a fast, safe, non-toxic alternative to the current users of HLD's. Sterilox's technology is based on the electrochemical activation of dilute brine solutions. The HLD produced is single-use and generated on-site and on demand at the point of use in hospitals, out-patient clinics and doctors' offices; any location in which rapid, high level disinfection of devices such as flexible endoscopes is required.
The Sterilox solution can be used in all standard washer/disinfectors or in manual systems to high level disinfect well-cleaned endoscopes or other heat sensitive systems. The Sterilox experience outside the US has focused on endoscopy suites, where the company's technology has successfully disinfected over 500,000 devices since its launch in 1999.
"The addition of the Sterilox System to the current HLD's available in the endoscopy suite and other appropriate locations will allow the U.S. to take advantage of the technology that has become one of the standards of care in markets outside the U.S., especially in the U.K.," said David W. Anderson, Sterilox Technologies president and CEO. "We are pleased with this action at FDA and look forward to the introduction of our technology to the U.S. market and to supplying the endoscopist with a new tool allowing them to provide safe and effective treatments to their patients."
Sterilox Technologies, Inc. is a leading developer and marketer of sterilization and disinfection generators and their solutions (Sterilox, Aqualox) based on the proprietary electrochemical activation of dilute brine solutions.
Source: PRNewswire
AHE Exchange Summit 2025 Brings EVS and Infection Prevention Experts Together in Columbus, Ohio
June 9th 2025The Association for the Health Care Environment (AHE) is set to host its largest event of the year—Exchange Summit 2025—from June 8 to 11 in Columbus, Ohio. With over 600 environmental services (EVS) professionals expected to attend, this year’s conference focuses heavily on infection prevention, interdepartmental collaboration, and education that empowers frontline health care support leaders to improve patient safety and operational efficiency.
Far UV-C Light Shows Promise for Decontaminating Medical Equipment in Clinical Settings
June 4th 2025Manual cleaning gaps on shared hospital equipment can undermine infection control efforts. New research shows far UV-C light can serve as a safe, automated backup to reduce contamination in real-world clinical settings.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
